Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8546)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 10, 2018 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Galvez M, Castaneda CA, Sanchez J, Castillo M, Rebaza LP, Calderon G, Cruz MDL, Cotrina JM, Abugattas J, Dunstan J, Guerra H, Mejia O, Gomez HL. Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy. World J Clin Oncol 2018; 9(2): 33-41 [PMID: 29651385 DOI: 10.5306/wjco.v9.i2.33] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v9/i2/33.htm |
| Number | Citing Articles |
| 1 |
Soeun Park, Eun-ki Min, Soong June Bae, Chihwan Cha, Dooreh Kim, Janghee Lee, Yoon Jin Cha, Sung Gwe Ahn, Joon Jeong. Relationship of the standard uptake value of 18F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91404-y
|
| 2 |
Ionut Flaviu Faur, Amadeus Dobrescu, Adelina Ioana Clim, Paul Pasca, Catalin Prodan-Barbulescu, Bogdan Daniel Gherle, Cristi Tarta, Alexandru Isaic, Dan Brebu, Ciprian Duta, Bogdan Totolici, Gabriel Lazar. The Value of Tumor Infiltrating Lymphocytes (TIL) for Predicting the Response to Neoadjuvant Chemotherapy (NAC) in Breast Cancer according to the Molecular Subtypes. Biomedicines 2023; 11(11): 3037 doi: 10.3390/biomedicines11113037
|
| 3 |
Jane L. Meisel, Jing Zhao, Aili Suo, Chao Zhang, Zhimin Wei, Caitlin Taylor, Ritu Aneja, Uma Krishnamurti, Zaibo Li, Rita Nahta, Ruth O’Regan, Xiaoxian Li. Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2–Directed Chemotherapy in HER2-Positive Breast Cancer. Clinical Breast Cancer 2020; 20(1): 19 doi: 10.1016/j.clbc.2019.09.003
|
| 4 |
Wakana Murakami, Mitsuhiro Tozaki, Michiro Sasaki, Akira I. Hida, Yasuyo Ohi, Kazunori Kubota, Yoshiaki Sagara. Correlation between 18F-FDG uptake on PET/MRI and the level of tumor-infiltrating lymphocytes (TILs) in triple-negative and HER2-positive breast cancer. European Journal of Radiology 2020; 123: 108773 doi: 10.1016/j.ejrad.2019.108773
|
| 5 |
Carlos Alexander Huertas-Caro, Mayra Alejandra Ramirez, Henry J. Gonzalez-Torres, María Carolina Sanabria-Salas, Silvia J. Serrano-Gómez. Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.910976
|
| 6 |
Murat Akyol, Alper Tuğral, Zeynep Arıbaş, Yeşim Bakar. Assessment of the cardiorespiratory fitness and the quality of life of patients with breast cancer undergoing chemotherapy: a prospective study. Breast Cancer 2023; 30(4): 617 doi: 10.1007/s12282-023-01453-6
|
| 7 |
Henry L. Gomez, Carlos Castañeda, Fernando Valencia, Rene Muñoz-Bermeo, Maria del Carmen Torrico, Silvia Neciosup. ABC4 Consensus: First Latin American Meeting—Assessment, Comments, and Application of Its Recommendations. JCO Global Oncology 2020; (6): 819 doi: 10.1200/GO.20.00081
|
| 8 |
Alberto Blanco Sánchez, Laura Yébenes, Alberto Berjón, David Hardisson. Evaluación de la respuesta patológica a quimioterapia neoadyuvante en cáncer de mama: correlación con el fenotipo molecular. Revista Española de Patología 2021; 54(1): 8 doi: 10.1016/j.patol.2020.07.003
|
| 9 |
Lin He, Yaling Wang, Qian Wu, Yuhua Song, Xuezhen Ma, Biyuan Zhang, Haiji Wang, Yong Huang. Association between levels of tumor-infiltrating lymphocytes in different subtypes of primary breast tumors and prognostic outcomes: a meta-analysis. BMC Women's Health 2020; 20(1) doi: 10.1186/s12905-020-01038-x
|
| 10 |
Guoxuan Gao, Zihan Wang, Xiang Qu, Zhongtao Zhang. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6668-z
|
| 11 |
Carlos A. Castaneda. Improving Oncology Worldwide. Sustainable Development Goals Series 2022; : 75 doi: 10.1007/978-3-030-96053-7_10
|
| 12 |
Matthew G. Davey, Ferdia Browne, Nicola Miller, Aoife J. Lowery, Michael J. Kerin. Pathological complete response as a surrogate to improved survival in human epidermal growth factor receptor-2-positive breast cancer: systematic review and meta-analysis. BJS Open 2022; 6(3) doi: 10.1093/bjsopen/zrac028
|
| 13 |
Carlos A Castaneda, Miluska Castillo, Karina Aliaga, Luis A Bernabe, Sandro Casavilca, Joselyn Sanchez, Carlos A Torres-Cabala, Henry L Gomez, Luis Mas, Jorge Dunstan, Jose M Cotrina, Julio Abugattas, Ivan Chavez, Eloy Ruiz, Paola Montenegro, Victor Rojas, Enrique Orrego, Marco Galvez-Nino, Brayam Felix, Maria P Landa-Baella, Tatiana Vidaurre, Maria R Villa, Rocio Zevallos, Luis Taxa, Henry Guerra. Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies. Biomarkers in Medicine 2019; 13(17): 1481 doi: 10.2217/bmm-2019-0178
|
| 14 |
Hiroki Kusama, Nobuyoshi Kittaka, Ai Soma, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Yukiko Seto, Jun Okuno, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Keiichiro Honma, Yasuhiro Tamaki, Takahiro Nakayama. Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer. Breast Cancer 2023; 30(6): 1085 doi: 10.1007/s12282-023-01504-y
|
| 15 |
K. Wimmer, M. Bolliger, Z. Bago-Horvath, G. Steger, D. Kauer-Dorner, R. Helfgott, C. Gruber, F. Moinfar, M. Mittlböck, F. Fitzal. Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival. Annals of Surgical Oncology 2020; 27(5): 1700 doi: 10.1245/s10434-019-08089-x
|
| 16 |
Krishnakumar Rathnam, K. Niraimathi, Hemant Deepak Shewade, Chenappa N. Patil, Neelesh Reddy, Ramanan Ganapathy, Murugesan Janarthinakani, Kosanam S. Kirushnakumar, R. Vijayabhaskar, P. Anandaselvakumar, S. V. Saju, Manjunath Nandennavar, Shashidhar V. Karpurmath, Arun Seshachalam. Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India. Indian Journal of Gynecologic Oncology 2020; 18(2) doi: 10.1007/s40944-020-0381-3
|
| 17 |
Ying Luo, Wei Zhang, Liang Xu, Yajun Chen, Yao Xu, Lin Yuan. Long Non-Coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2. Technology in Cancer Research & Treatment 2020; 19: 153303382098076 doi: 10.1177/1533033820980763
|
| 18 |
Anil Yıldiz, Ahmet Bilici, Ozgur Acikgoz, Jamshid Hamdard, Pelin Basim, Tansel Cakir, Asli Cakir, Omer Fatih Olmez, Cem Gezen, Ozcan Yildiz. Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes. Journal of Chemotherapy 2024; : 1 doi: 10.1080/1120009X.2024.2314830
|
| 19 |
Rania M. Sidahmed, Abdalraheem A. Babiker, Elhadi A. Ahmed, Alaa E. Abbas. Assessment of HER2/neu among Female with Invasive Ductal Breast Carcinoma, Using Manual Tissue Microarray Technology in Khartoum State, Sudan. European Journal of Biomedical Research 2022; 1(4): 10 doi: 10.24018/ejbiomed.2022.1.4.20
|